Search

everythinglearnresearchcommunity

for

Search:↓

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.